Hollow structured upconversion luminescent NaYF₄:Yb³⁺, Er³⁺ nanospheres for cell imaging and targeted anti-cancer drug delivery.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23199935.
- Also identified by DOI 10.1016/j.biomaterials.2012.11.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Uniform α-NaYF₄:Yb³⁺, Er³⁺ nanospheres (∼130 nm) with mesoporous shell and hollow interior structure were synthesized by using Y(OH)CO₃:Yb³⁺, Er³⁺ nanospheres (NPs) as sacrificial templates via a surface-protected "etching" and hydrothermal ion-exchange process. In this process, polyethylenimine (PEI) ligands played a key role in formation of the hollow structured α-NaYF₄ nanospheres, i.e., they can effectively protect the surface of the Y(OH)CO₃ from rapid dissolution by H(+). Moreover, folic acid (FA), a commonly used cancer-targeting agent was conjugated on the surface of NPs based on the presence of free amine groups. The as-prepared FA-modified hollow NPs can be performed as anti-cancer drug carriers for the investigation of drug storage/release properties, which exhibit greater cytotoxicity than DOX-loaded α-NaYF₄ NPs due to the specific cell uptake by HeLa cells via FA receptor-mediate endocytosis. Furthermore, upconversion (UC) luminescence images of FA-modified α-NaYF₄:Yb³⁺, Er³⁺ NPs uptaken by cells shows bright green emission without background noise under 980 nm infrared laser excitation. Thus, these multifunctional nanospheres combining UC luminescent property and hollow and mesoporous structure have potential for simultaneous targeted anti-cancer drug delivery and cell imaging.
Medical subject headings
- Doxorubicin
- Luminescent Measurements
- Nanocapsules
- Nanospheres